[1]
2024. The use of third-party service providers, so-called vendors, in the context of clinical trials of medicinal products for human use. TEST BioLaw Journal - Rivista di BioDiritto. 3 (Oct. 2024), 329–350. DOI:https://doi.org/10.15168/2284-4503-3203.